Prolonged skin allograft survival by IL-10 gene-introduced CD4 T cell administration

International Immunology

Volumn 17, Issue 6, 2005, Pages 759-768

  Miyamoto, Takeshi ^a   Kaneko, Takaaki ^a   Yamashita, Masakatsu ^a   Tenda, Yoshiyuki ^a   Inami, Masamichi ^a   Suzuki, Akane ^a   Ishii, Sohtaro ^a   Kimura, Motoko ^a   Hashimoto, Kahoko ^b   Shimada, Hideaki ^a   Yahata, Hiroshi ^c   Ochiai, Takenori ^a   Saito, Izumu ^d   DeGregori, James ^e   Nakayama, Toshinori ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Bm1; CAR Tg; Gene therapy; Skin graft

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; CYCLOSPORIN A; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; TACROLIMUS; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MANIPULATION; CONTROLLED STUDY; COXSACKIE VIRUS; CYTOKINE RELEASE; GENE TRANSFER; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; SPLEEN; SURVIVAL TIME; T LYMPHOCYTE; TH2 CELL; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; ADENOVIRUS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOLOGY; ENTEROVIRUS; GENETICS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; SKIN TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION;

ADENOVIRIDAE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENTEROVIRUS; GENE TRANSFER TECHNIQUES; GRAFT SURVIVAL; IMMUNOSUPPRESSION; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; SKIN TRANSPLANTATION; SPLEEN; T-LYMPHOCYTE SUBSETS; TACROLIMUS; TH2 CELLS;

EID: 26444518839     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh256     Document Type: Article

References (47)

1. + T-cell subsets in determining transplantation rejection or tolerance. Immunol. Rev. 182:164.
2. Rocha, P. N., Plumb, T. J., Crowley, S. D. and Coffman, T. M. 2003. Effector mechanisms in transplant rejection. Immunol. Rev. 196:51.
3. Nickerson, P., Steiger, J., Zheng, X. X. et al. 1997. Manipulation of cytokine networks in transplantation: False hope or realistic opportunity for tolerance? Transplantation 63:489.
4. Piccotti, J. R., Chan, S. Y., VanBuskirk, A. M., Eichwald, E. J. and Bishop, D. K. 1997. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 63:619.
5. Ruhlmann, A. and Nordheim, A. 1997. Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation. Immunobiology 198:192.
6. Schreiber, S. L. and Crabtree, G. R. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136.
7. Kahan, B. D. 1993. Cyclosporine: The base for immunosuppressive therapy - present and future. Transplant. Proc. 25:508.
8. Starzl, T. E. 1993. FK 506 versus cyclosporine. Transplant. Proc. 25:511.
9. Qin, L., Chavin, K. D., Ding, Y. et al. 1996. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J. Immunol. 156:2316.
10. Brauner, R., Nonoyama, M., Laks, H. et al. 1997. Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival. J. Thorac. Cardiovasc. Surg. 114:923.
11. Shinozaki, K., Yahata, H., Tanji, H., Sakaguchi, T., Ito, H. and Dohi, K. 1999. Allograft transduction of IL-10 prolongs survival following orthotopic liver transplantation. Gene Ther. 6:816.
12. David, A., Chetritt, J., Guillot, C. et al. 2000. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther. 7:505.
13. Klebe, S., Sykes, P., Coster, D., Krishnan, R. and Williams, K. 2001. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 71:1214.
14. Lundstrom, K. 2003. Latest development in viral vectors for gene therapy. Trends Biotechnol. 21:117.
15. - SCID: Initial trial results after 4 years. Science 270:475.
16. Verma, I. M. and Somia, N. 1997. Gene therapy - promises, problems and prospects. Nature 389:239.
17. Anderson, W. F. 1998. Human gene therapy. Nature 392:25.
18. Benihoud, K., Yeh, P. and Perricaudet, M. 1999. Adenovirus vectors for gene delivery. Curr. Opin. Biotechnol. 10:440.
19. Kafri, T., Morgan, D., Krahl, T., Sarvetnick, N., Sherman, L. and Verma, I. 1998. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy. Proc. Natl Acad. Sci. USA 95:11377.
20. Molinier-Frenkel, V., Gahery-Segard, H., Mehtali, M. et al. 2000. Immune response to recombinant adenovirus in humans: Capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J. Virol. 74:7678.
21. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
22. Kennedy, M. K., Picha, K. S., Shanebeck, K. D., Anderson, D. M. and Grabstein, K. H. 1994. Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur. J. Immunol. 24:2271.
23. + T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 389:737.
24. Buer, J., Lanoue, A., Franzke, A., Garcia, C., von Boehmer, H. and Sarukhan, A. 1998. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187:177.
25. Wan, Y. Y., Leon, R. P., Marks, R. et al. 2000. Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells. Proc. Natl Acad. Sci. USA 97:13784.
26. + cells by CD4. Science 249:1558.
27. Kanegae, Y., Lee, G., Sato, Y. et al. 1995. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:3816.
28. Omori, M., Yamashita, M., Inami, M. et al. 2003. CD8 T cell-specific downregulation of histone hyperacetylation and gene activation of the IL-4 gene locus by ROG, repressor of GATA. Immunity 19:281.
29. Yamashita, M., Kimura, M., Kubo, M. et al. 1999. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl Acad. Sci. USA 96:1024.
30. Inamura, N., Nakahara, K., Kino, T. et al. 1988. Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Transplantation 45:206.
31. Wekerle, T., Sayegh, M. H., Hill, J. et al. 1998. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187:2037.
32. Wissing, K. M., Morelon, E., Legendre, C. et al. 1997. A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy. Transplantation 64:999.
33. Chernoff, A. E., Granowitz, E. V., Shapiro, L. et al. 1995. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154:5492.
34. Ettinghausen, S. E. and Rosenberg, S. A. 1986. Immunotherapy of murine sarcomas using lymphokine activated killer cells: Optimization of the schedule and route of administration of recombinant interleukin-2. Cancer Res. 46:2784.
35. Chen, D., Sung, R. and Bromberg, J. S. 2002. Gene therapy in transplantation. Transplant Immunol. 9:301.
36. Drazan, K. E., Wu, L., Olthoff, K. M., Jurim, O., Busuttil, R. W. and Shaked, A. 1995. Transduction of hepatic allografts achieves local levels of viral IL-10 which suppress alloreactivity in vitro. J. Surg. Res. 59:219.
37. Wang, C. K., Zuo, X. J., Carpenter, D. et al. 1999. Prolongation of cardiac allograft survival with intracoronary viral interleukin-10 gene transfer. Transplant. Proc. 31:951.
38. Tung, T. C., Oshima, K., Cui, G., Laks, H. and Sen, L. 2003. Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts. Am. J. Physiol. Heart Circ. Physiol. 285:H964.
39. Sen, L., Hong, Y. S., Luo, H., Cui, G. and Laks, H. 2001. Efficiency, efficacy, and adverse effects of adenovirus vs. liposome-mediated gene therapy in cardiac allograffs. Am. J. Physiol. Heart Circ. Physiol. 281:H1433.
40. Oshima, K., Sen, L., Cui, G. et al. 2002. Localized interleukin-10 gene transfer induces apoptosis of alloreactive T cells via FAS/FASL pathway, improves function, and prolongs survival of cardiac allograft. Transplantation 73:1019.
41. Hong, Y. S., Laks, H., Cui, G., Chong, T. and Sen, L. 2002. Localized immunosuppression in the cardiac allograft induced by a new liposome-mediated IL-10 gene therapy. J. Heart Lung Transplant. 21:1188.
42. Itano, H., Mora, B. N., Zhang, W. et al. 2001. Lipid-mediated ex vivo gene transfer of viral interleukin 10 in rat lung allotransplantation. J. Thorac. Cardiovasc. Surg. 122:29.
43. de Perrot, M., Fischer, S., Liu, M. et al. 2003. Impact of human interleukin-10 on vector-induced inflammation and early graft function in rat lung transplantation. Am. J. Respir. Cell Mol. Biol. 28:616.
44. Coates, T., Krishnan, R., Chew, G. et al. 2001. Dendritic cell TH2 cytokine gene therapy in sheep. Transplant. Proc. 33:180.
45. McDonald, D., Stockwin, L., Matzow, T., Blair Zajdel, M. E. and Blair, G. E. 1999. Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells. Gene Ther. 6:1512.
46. Fechner, H., Haack, A., Wang, H. et al. 1999. Expression of coxsackie adenovirus receptor and alphas integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther. 6:1520.
47. Letterio, J. J. and Roberts, A. B. 1998. Regulation of immune responses by TGF-b. Annu. Rev. Immunol. 16:137.